Press Releases

All Releases
View Summary ARYx Therapeutics Inc. Updates Progress with Tecarfarin EmbraceAC Study
Jun 16, 2009
PDF 14.0 KB Add to Briefcase
View Summary ARYx to Present at the Jefferies 3rd Annual Healthcare Conference
Jun 10, 2009
PDF 9.5 KB Add to Briefcase
View Summary ARYx Reports First Quarter 2009 Results and Earnings
May 14, 2009
PDF 19.0 KB Add to Briefcase
View Summary ARYx Therapeutics Schedules First Quarter 2009 Results and Earnings Call
May 7, 2009
PDF 9.7 KB Add to Briefcase
View Summary ARYx Reports Fourth Quarter and Full Year 2008 Results of Operations
Mar 26, 2009
PDF 21.1 KB Add to Briefcase
View Summary ARYx Therapeutics Schedules Fourth Quarter and Year End 2008 Results and Earnings Call
Mar 19, 2009
PDF 9.7 KB Add to Briefcase
View Summary ARYx to Present at the Cowen and Company 29th Annual Healthcare Conference
Mar 13, 2009
PDF 9.5 KB Add to Briefcase
View Summary ARYx Therapeutics, Inc. Provides Additional Data on Atrial Fibrillation Clinical Trial on ATI-2042
Jan 12, 2009
PDF 17.5 KB Add to Briefcase
View Summary ARYx Therapeutics, Inc. Announces Successful Outcome of Atrial Fibrillation Clinical Trial on ATI-2042
Dec 18, 2008
PDF 18.7 KB Add to Briefcase
View Summary ARYx to Present at the Piper Jaffray 20th Annual Healthcare Conference
Nov 25, 2008
PDF 9.5 KB Add to Briefcase
View Summary ARYx Therapeutics Presents Clinical Data for ATI-5923 at American Heart Association Scientific Sessions 2008
Nov 14, 2008
PDF 15.3 KB Add to Briefcase
View Summary ARYx Reports Third Quarter 2008 Financial Results
Nov 12, 2008
PDF 18.2 KB Add to Briefcase
View Summary ARYx Therapeutics Inc. Announces $21.6 Million Private Placement -- New Funding Improves Strategic Position for Product Collaborations
Nov 12, 2008
PDF 11.2 KB Add to Briefcase
View Summary ARYx Therapeutics Schedules Third Quarter 2008 Results and Earnings Call
Nov 5, 2008
PDF 9.5 KB Add to Briefcase
View Summary ARYx Therapeutics Inc. Completes Enrollment in EmbraceAC Study -- Phase 2/3 Clinical Trial Comparing Anticoagulant ATI-5923 Against Warfarin
Nov 3, 2008
PDF 14.0 KB Add to Briefcase
View Summary ARYx to Present at the Oppenheimer & Co. 19th Annual Health Care Conference
Oct 28, 2008
PDF 9.3 KB Add to Briefcase
View Summary ARYx Therapeutics Appoints Amgen Executive to Board of Directors
Aug 29, 2008
PDF 10.1 KB Add to Briefcase
View Summary ARYx Therapeutics, Inc. Announces Successful Results of Chronic Constipation Clinical Trial on ATI-7505
Aug 22, 2008
PDF 14.3 KB Add to Briefcase
View Summary ARYx Reports Second Quarter 2008 Financial Results
Aug 13, 2008
PDF 18.3 KB Add to Briefcase
View Summary ARYx Therapeutics Schedules Second Quarter 2008 Results and Earnings Call
Aug 6, 2008
PDF 9.9 KB Add to Briefcase
Showing 1-20 of 58 Page: 1 2 3  Next 20
= add release to Briefcase
Stock Information
NASDAQ:ARYX
$4.52   + 0.05
Jul 2, 2009
4:12 PM ET
Quotes delayed at least 20 minutes.
Information provided by eSignal.
 ARYx Therapeutics Final
     Prospectus

Corporate Presentation

Learn more about our products, technology, and financial history by viewing our Corporate Presentation.

Learn More